Lupin
CMP: Rs 721
Target Price: Rs 938
Recommended By: Citigroup Global Markets
Reasons: Small acquisitions and the buyout of a majority stake in Pharma Dynamics of South Africa
Rating: Medium risk
Opto Circuits
CMP: Rs 287.25
Target Price: Rs 463
Recommended By: Kotak Securities
Reasons: Strong market positioning, potential introduction of new products, front end R&D set up (with the Criticare acquisition) and strong management.
Rating: Low risk
DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.
No comments:
Post a Comment